Notifications
2015_11_01 Data Snapshot

Table 1.  Get Full Table

Barcode UUID Date Type Category Notes
TCGA-CD-5813 152b9d8a-19fd-4665-b9e4-4fedfb1608cd 03/13/2011 STAD Item in special subset Sample is Signet Ring subtype. Program Office determined this will be a Notification.
TCGA-CG-4444 5c087d33-0bd3-407d-8350-fabba6aec597 10/31/2012 STAD Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-CG-4460 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab 10/31/2012 STAD Prior malignancy Prior malignancy ovarian cancer treated with chemotherapy.
TCGA-CG-4460 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy ovarian cancer treated with chemotherapy.
TCGA-CG-4475 cad2adc1-0f41-4651-9c80-ae9961e2dc8d 10/31/2012 STAD Prior malignancy Prior malignancy of the prostate, bladder, and testicle. No systemic chemotherpay or radiation.
TCGA-CG-4476 442d7415-d095-4962-8296-a14390bad40a 10/31/2012 STAD Prior malignancy Prior malignancy of the prostate. No systemic chemotherpay or radiation.
TCGA-CG-5716 49587564-e30f-4f1c-b7b3-fc0989bb1a0a 10/31/2012 STAD Prior malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-CG-5716 49587564-e30f-4f1c-b7b3-fc0989bb1a0a 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-CG-5727 b75eb694-8e9d-4dbb-b536-7d278c728cbb 05/17/2013 STAD Synchronous malignancy Patient had a synchronous malignant neoplasm of the colon. No systemic radation or chemotherapy.
TCGA-EQ-A4SO fe1ad544-3189-4495-86be-0c68f3234238 02/22/2013 STAD Prior malignancy Patient had a prior basal cell carcinoma of the skin. No radiation or systemic chemotherapy.
TCGA-F1-6177 c3cba26e-38c2-4569-afd6-6b045e604808 10/31/2012 STAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-HF-7131 06fd3086-0801-4d74-bced-4916efc544d2 10/31/2012 STAD Prior malignancy Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate.
TCGA-HF-7131 06fd3086-0801-4d74-bced-4916efc544d2 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate.
TCGA-HU-A4H6 416fd59b-a4f8-4610-9f8b-473cb5c04a4a 08/04/2015 STAD Neoadjuvant therapy Dates on Enrollment and Pharmaceutical forms are inconsistent. Neoadjuvant therapy prior to TCGA procurement can not be verified as TSS is non-responsive.
TCGA-IC-A6RF 9dfddc49-1e66-4e26-9d71-40d748cca0a6 08/26/2014 ESCA History of unacceptable prior treatment related to a prior/other malignancy During Enrollment it was found that the patient had a prior right breast malignancy and recieved systemic pharma treatment (cytoxan and taxotere).
TCGA-L5-A43M 29da08f4-c9e2-4e7a-9733-b4ec5b9c5f13 02/01/2013 ESCA Prior malignancy Patient had a prior colon cancer. No radiation or systemic chemotherapy.
TCGA-L5-A88T 6826bcdd-24a4-4dd1-9fab-201cf774e166 06/16/2014 ESCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-V5-A7RE-11A 7c5a7626-d549-45c0-ae47-5dee771ac0b0 01/19/2015 ESCA Item does not meet study protocol The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped.
TCGA-V5-A7RE-11A 7c5a7626-d549-45c0-ae47-5dee771ac0b0 01/20/2015 ESCA Pathology outside specification The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped.